Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trialMatthew D. Galsky, Enrique Grande, Mustafa Özgüroğlu et al.|The Lancet|2020Cited by 786
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)Francesco Soria, George N. Thalmann, Shahrokh F. Shariat et al.|World Journal of Urology|2016Cited by 471
Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over TimeGuillaume Ploussard, Wassim Kassouf, Shahrokh F. Shariat et al.|European Urology|2013Cited by 147
Impact of Histological Variants on Clinical Outcomes of Patients with Upper Urinary Tract Urothelial CarcinomaMichael Rink, Shahrokh F. Shariat, Brian D. Robinson et al.|The Journal of Urology|2012Cited by 142
Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 PatientsLuis A. Kluth, Shahrokh F. Shariat, Malte Rieken et al.|European Urology|2013Cited by 117